Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes

Berezhkovskiy, 2011, The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation, J Pharm Sci, 100, 1167, 10.1002/jps.22324

Blouin, 1977, Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study, J Cell Biol, 72, 441, 10.1083/jcb.72.2.441

Daniel, 2003, Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions, Prog Neuropsychopharmacol Biol Psychiatry, 27, 65, 10.1016/S0278-5846(02)00317-2

Daniel, 1999, Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants, Eur Neuropsychopharmacol, 9, 483, 10.1016/S0924-977X(99)00034-6

Daniel, 1999, The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions, Toxicol Appl Pharmacol, 158, 115, 10.1006/taap.1999.8688

de Duve, 1974, Commentary. Lysosomotropic agents, Biochem Pharmacol, 23, 2495, 10.1016/0006-2952(74)90174-9

Feng, 1992, A novel mechanism for regulation of vacuolar acidification, J Biol Chem, 267, 19769, 10.1016/S0021-9258(19)88619-2

Funk, 2012, Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction, Mol Pharm, 9, 1384, 10.1021/mp200641e

Gotink, 2015, Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib, Cell Oncol (Dordr), 38, 119, 10.1007/s13402-015-0218-8

Guo, 2018, Advancing predictions of tissue and intracellular drug concentrations using in vitro, imaging and physiologically based pharmacokinetic modeling approaches, Clin Pharmacol Ther, 104, 865, 10.1002/cpt.1183

Hallifax, 2012, Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs, J Pharm Sci, 101, 2645, 10.1002/jps.23202

Kazmi, 2013, Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells), Drug Metab Dispos, 41, 897, 10.1124/dmd.112.050054

Kharbanda, 1997, Flow cytometric analysis of vesicular pH in rat hepatocytes after ethanol administration, Hepatology, 26, 929, 10.1002/hep.510260419

Kornhuber, 2010, Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system, J Cell Physiol, 224, 152, 10.1002/jcp.22112

Kreamer, 1986, Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations, In Vitro Cell Dev Biol, 22, 201, 10.1007/BF02623304

Lemieux, 2004, Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99, Anal Biochem, 327, 247, 10.1016/j.ab.2004.01.010

MacIntyre, 1988, The potential role of lysosomes in tissue distribution of weak bases, Biopharm Drug Dispos, 9, 513, 10.1002/bod.2510090602

MacIntyre, 1988, Role of lysosomes in hepatic accumulation of chloroquine, J Pharm Sci, 77, 196, 10.1002/jps.2600770303

Mindell, 2012, Lysosomal acidification mechanisms, Annu Rev Physiol, 74, 69, 10.1146/annurev-physiol-012110-142317

Nadanaciva, 2011, A high content screening assay for identifying lysosomotropic compounds, Toxicol In Vitro, 25, 715, 10.1016/j.tiv.2010.12.010

Ndolo, 2012, Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro, PLoS One, 7, e49366, 10.1371/journal.pone.0049366

Poulin, 2012, In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods, J Pharm Sci, 101, 838, 10.1002/jps.22792

Reasor, 2006, Drug-induced phospholipidosis: issues and future directions, Expert Opin Drug Saf, 5, 567, 10.1517/14740338.5.4.567

Regec, 1989, Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility, Biochem Pharmacol, 38, 2527, 10.1016/0006-2952(89)90098-1

Reichel, 2016, Pharmacokinetics in drug discovery: an exposure-centred approach to optimising and predicting drug efficacy and safety, Handb Exp Pharmacol, 232, 235, 10.1007/164_2015_26

Tietz, 1990, Time-dependent effects of chloroquine on pH of hepatocyte lysosomes, Biochem Pharmacol, 40, 1419, 10.1016/0006-2952(90)90414-G

Ufuk, 2015, In vitro assessment of uptake and lysosomal sequestration of respiratory drugs in alveolar macrophage cell line NR8383, Pharm Res, 32, 3937, 10.1007/s11095-015-1753-8

Wang, 2017, Quantitative mapping of the spatial distribution of nanoparticles in endo-lysosomes by local pH, Nano Lett, 17, 1226, 10.1021/acs.nanolett.6b05041

Zhitomirsky, 2016, Lysosomes as mediators of drug resistance in cancer, Drug Resist Updat, 24, 23, 10.1016/j.drup.2015.11.004